In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification

Molecular Immunology
Stefan SteidlElisabeth Thomassen-Wolf

Abstract

The mammalian immune system applies somatic hypermutation to select for antibodies with improved dissociation rates in vivo up to an intrinsic limit, previously termed as affinity ceiling. However, for certain therapeutic applications it may be desirable to further improve antibody affinities beyond that limit. In this study the selection of antibodies specific for the pro-inflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) from the HuCAL GOLD human antibody library is described. In order to increase affinity and also functional activity, in vitro affinity maturation of a pool of lead Fab candidates was carried out. CDR-L3 and parallel CDR-H2 diversification using trinucleotide consensus cassettes were followed by the combination of optimized CDR-L3 and CDR-H2 leading to a 5000-fold improved affinity finally reaching a K(D) of 400 fM. Cytokine neutralizing potential of MOR04357 was evaluated in a TF-1 proliferation assay. Along with affinity optimization a 2000-fold increase in potency was observed compared to the parental antibody. Due to species cross-reactivity MOR04357 also blocks rat GM-CSF induced proliferation of FDCP-1 cells. Receptor inhibition studies showed that MOR04357 prevents the inter...Continue Reading

References

Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K HayashidaA Miyajima
Jun 5, 1987·Science·S C Clark, R Kamen
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J C GassonD W Golde
Jan 1, 1995·Rheumatology International·A L BellA E Irvine
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J Foote, H N Eisen
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·C F BarbasD R Burton
Oct 11, 1996·Journal of Molecular Biology·R M MacCallumJ M Thornton
Apr 20, 2000·The Journal of Investigative Dermatology·M SchönM P Schön
Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S S ChengS L Kunkel
Oct 3, 2001·The Journal of Experimental Medicine·J L McQualterC C Bernard
Jul 23, 2002·Trends in Immunology·John A Hamilton
Nov 15, 2002·Journal of Biomedical Science·M S ChoS Chan
Aug 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tara M C HornellElizabeth D Mellins
Nov 18, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Steven BozinovskiGary P Anderson
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julian Gomez-CambroneroMichael A Baumann
Apr 15, 2004·Analytical Biochemistry·Andrew W DrakeScott L Klakamp
Dec 29, 2004·Growth Factors·John A Hamilton, Gary P Anderson
Jun 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Arvind RajpalRoberto Crea
Jul 26, 2005·Biochemical and Biophysical Research Communications·Palaniswami RathanaswamiJohn Babcook
Mar 1, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jian LiLuigi Grasso
May 16, 2006·Molecular Immunology·Eva-Maria KrinnerJulia Hepp
Jul 11, 2006·Advanced Drug Delivery Reviews·Kim L Wark, Peter J Hudson
Sep 27, 2006·Trends in Biotechnology·Patrick DufnerRalph R Minter
Mar 3, 2007·Annual Review of Biochemistry·Javier M Di Noia, Michael S Neuberger

❮ Previous
Next ❯

Citations

Apr 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yanni WangJohn W Schrader
Feb 4, 2010·Protein Engineering, Design & Selection : PEDS·Hiroto IwaiHiroshi Ueda
Jun 18, 2011·Protein Engineering, Design & Selection : PEDS·E-C BrockmannU Lamminmäki
Aug 10, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Stefan HarthThomas Dieter Mueller
Oct 21, 2015·Biotechnology Advances·Katherine GroffAmy J Clippinger
Nov 1, 2015·Protein Engineering, Design & Selection : PEDS·Alfred W Y LimJulian E Sale
Apr 9, 2011·New Biotechnology·Thomas Tiller
Feb 26, 2016·Expert Opinion on Biological Therapy·Bharath WootlaMoses Rodriguez
Dec 25, 2010·British Journal of Pharmacology·Jamie CampbellMatthew A Sleeman
Dec 18, 2009·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Jun 3, 2014·European Journal of Microbiology & Immunology·A M Shukra Kapil Maithal
Aug 3, 2013·Analytical Biochemistry·Francisco YleraAchim Knappik
Jun 4, 2016·Biologicals : Journal of the International Association of Biological Standardization·YanMin ChenJieChao Yin
Jan 10, 2018·Clinical and Experimental Immunology·S AliverniniI B McInnes
May 5, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dirk PonselKathrin Tissot
Jun 17, 2015·Nature Communications·Luca PiccoliAntonio Lanzavecchia
Aug 2, 2014·Expert Review of Neurotherapeutics·Francesco PanzaGiancarlo Logroscino
Jul 17, 2015·Journal of Biomolecular Screening·Daniela Della DucataBodo Brocks
Dec 4, 2015·Nature Reviews. Rheumatology·Ian P Wicks, Andrew W Roberts
Jul 4, 2020·Proceedings of the National Academy of Sciences of the United States of America·Denice T Y ChanMaria A T Groves
Sep 29, 2020·Frontiers in Immunology·Mohamed A AlfalehAnwar M Hashem
Dec 7, 2018·Neurology and Therapy·Jehan AramCris S Constantinescu
Oct 9, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jian HuNai-Kong V Cheung
Jul 11, 2012·Molecular Cancer Therapeutics·Yoko MatsudaToshiyuki Ishiwata
Dec 15, 2020·Protein Science : a Publication of the Protein Society·Shuhao LiHaiming Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.